Checkpoint Inhibitors

< All comics

Checkpoint Inhibitors

Checkpoint Inhibitors (CPIs) are an important immuno-therapy approach for patients with certain cancers. In this #HowCellsWork story, we examine how different types of CPIs work to allow T cells to attack tumors. Check out our cell stories here:

Posted June 24, 2022 · Follow Us:

< Previous Comic

All Comics in the Oncology Series

Checkpoint Inhibitors

Jun 24, 2022

The Link Between HPV and Cervical Cancer

At SQZ Biotechnologies, we are committed to the fight against this disease with our first clinical program. In this #HowCellsWork episode, we examine HPV infection, cancer cell formation, and the important role of PAP smears for early diagnosis.

Feb 5, 2022

MHC-II vs MHC-I Presentation

It’s important to tailor presentations to your target audience - even in the immune system. Different presentation mechanisms in APCs prioritize CD8 Killer T cells versus CD4 Helper T cells. In this #HCW episode, we illustrate how prioritizing presentation to CD8 Killer T cells leads to stronger anti-tumor effects.

Feb 5, 2022